Article Per Year (5 Year)
p-Index From 2021 - 2026
0.23
P-Index
This Author published in this journals
All Journal Cermin Dunia Kedokteran
Muhammad Alifian Remifta Putra
Faculty of Medicine, University of Indonesia, Jakarta, Indonesia
Health Professions

Published : 1 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 1 Documents
Search

 1 
Tata Laksana Komprehensif Terkini Penanganan Re-Emergensi Hand, Foot, and Mouth Disease (HFMD) di Indonesia: Tinjauan Lingkup: Tinjauan Pustaka Muhammad Alifian Remifta Putra
Cermin Dunia Kedokteran Vol 51 No 10 (2024): Infeksi
Publisher : PT Kalbe Farma Tbk.

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.55175/cdk.v51i10.1122

Abstract

Hand, foot, and mouth disease (HFMD) is an exanthematous disease with the main manifestation of a maculopapular rash eruption on the hands, feet, and mouth accompanied by fever with potentially serious complications in children under five-years-old. Indonesia has a recurring cycle of HFMD outbreaks, making it a re-emergent disease. The author conducted a systematic search in three databases, including Pubmed, Wiley Online Library, and Science Direct, with the keywords "hand, foot, and mouth disease,"enterovirus", and "therapy," published from 2000 until 2023. A total of 791 studies were included in the analysis, and their quality was assessed using the Newcastle-Ottawa Scale. The currently available comprehensive HFMD management includes prevention, therapy, and complication management. Current research has not succeeded in uncovering a definitive treatment; thus, management focused on symptomatics, followed by isolation with good oral and skin care. In severe cases, available options include antiviral therapy and intravenous immunoglobulin, along with respiratory and blood circulation system support. Research has shown that the inactivated Enterovirus A71 (EV-A71) vaccine is the most effective and cost-effective option. However, the evolution of enterovirus epidemiology caused one agent intervention that will be inadequate in the future; thus, developing definitive treatments and effective multivalent vaccines is essential.
Co-Authors